Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 6, 1999

Primary Completion Date

July 31, 2001

Conditions
Head and Neck Cancer
Interventions
DRUG

carboplatin

DRUG

paclitaxel

Trial Locations (18)

14642

University of Rochester Cancer Center, Rochester

19111

Fox Chase Cancer Center, Philadelphia

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

30322

Emory University Hospital - Atlanta, Atlanta

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

55416

CCOP - Metro-Minnesota, Saint Louis Park

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Veterans Affairs Medical Center - Chicago (Lakeside), Chicago

61602

CCOP - Illinois Oncology Research Association, Peoria

94304

Veterans Affairs Medical Center - Palo Alto, Palo Alto

94305-5408

Stanford University Medical Center, Stanford

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

49007-3731

CCOP - Kalamazoo, Kalamazoo

07018-1095

Veterans Affairs Medical Center - East Orange, East Orange

07601

CCOP - Northern New Jersey, Hackensack

44106-5065

Ireland Cancer Center, Cleveland

37232-6838

Vanderbilt Cancer Center, Nashville

0001

Pretoria Academic Hospital, Pretoria

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003206 - Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | Biotech Hunter | Biotech Hunter